Regeneron Announces Presentation at the UBS Global Life Sciences Conference

Fri. September 19, 2008; Posted: 09:30 AM

TARRYTOWN, N.Y., Sep 19, 2008 (BUSINESS WIRE) -- REGN | Quote | Chart | News | PowerRating -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN | Quote | Chart | News | PowerRating) will webcast its presentation at the UBS Global Life Sciences Conference on Tuesday, September 23, 2008. The presentation will provide an overview of the Company and its clinical and research programs and is scheduled to be broadcast live on Tuesday, September 23 at 4:30 p.m. Eastern Time. The session may be accessed through the Company's web site (www.regeneron.com on the Investor Relations page, under the Presentations heading) at the time of the presentation. An archived version of the presentation will be available after the live webcast through October 25, 2008. Additional information about Regeneron and recent news releases are available on the Regeneron worldwide web site at www.regeneron.com.

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST(R) (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases and has preclinical programs in other diseases and disorders.

SOURCE: Regeneron Pharmaceuticals, Inc.

for Regeneron Pharmaceuticals, Inc. Investor Relations, 914-345-7640 invest@regeneron.com or Laura Lindsay, 914-345-7800 laura.lindsay@regeneron.com or Lauren Tortorete, 212-845-5609 ltortorete@biosector2.com

For full details on Regeneron Pharm Inc (REGN) click here. Regeneron Pharm Inc (REGN) has Short Term PowerRatings of 6. Details on Regeneron Pharm Inc (REGN) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News | Stock Index

Archives

Feedback

Email Article Link

Close X

RELATED SITES

Please call 1-213-955-5858 ext. 1

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.